Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 20 12:12PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-3.77 Insider Own19.62% Shs Outstand46.72M Perf Week1.62%
Market Cap1.19B Forward P/E- EPS next Y-0.01 Insider Trans-0.33% Shs Float37.89M Perf Month5.76%
Income-156.05M PEG- EPS next Q-0.44 Inst Own97.89% Short Float22.45% Perf Quarter-13.44%
Sales224.00M P/S5.30 EPS this Y64.13% Inst Trans11.37% Short Ratio17.81 Perf Half Y-16.92%
Book/sh4.99 P/B5.05 EPS next Y99.41% ROA-31.67% Short Interest8.50M Perf Year-3.34%
Cash/sh6.43 P/C3.92 EPS next 5Y- ROE-83.06% 52W Range23.14 - 35.56 Perf YTD-14.70%
Dividend Est.- P/FCF- EPS past 5Y-39.57% ROI-28.80% 52W High-29.19% Beta1.10
Dividend TTM- Quick Ratio3.47 Sales past 5Y88.90% Gross Margin74.22% 52W Low8.82% ATR (14)1.10
Dividend Ex-Date- Current Ratio3.68 EPS Y/Y TTM-3.30% Oper. Margin-47.31% RSI (14)50.46 Volatility4.06% 4.29%
Employees264 Debt/Eq1.31 Sales Y/Y TTM133.90% Profit Margin-69.67% Recom1.09 Target Price47.55
Option/ShortYes / Yes LT Debt/Eq1.31 EPS Q/Q32.64% Payout- Rel Volume0.56 Prev Close24.07
Sales Surprise-1.29% EPS Surprise-28.48% Sales Q/Q119.07% EarningsMay 08 AMC Avg Volume477.42K Price25.18
SMA200.68% SMA50-1.12% SMA200-10.25% Trades Volume119,522 Change4.61%
Date Action Analyst Rating Change Price Target Change
Apr-17-24Initiated Stifel Buy $48
Dec-18-23Reiterated H.C. Wainwright Buy $60 → $58
Nov-20-23Resumed JP Morgan Overweight $37
Nov-13-23Initiated Morgan Stanley Overweight $60
Oct-24-23Initiated Cantor Fitzgerald Overweight $50
Oct-17-23Resumed Evercore ISI Outperform $62
Sep-20-23Initiated JMP Securities Mkt Outperform $70
Sep-01-22Initiated Citigroup Buy $38
Sep-20-21Initiated JP Morgan Overweight $30
Aug-07-20Upgrade Raymond James Outperform → Strong Buy $28 → $48
May-18-24 07:00AM
May-13-24 09:40AM
May-10-24 07:30PM
11:46AM Loading…
May-09-24 11:46AM
May-08-24 04:02PM
May-07-24 04:10PM
May-02-24 02:33PM
May-01-24 04:10PM
Apr-25-24 10:02AM
09:30PM Loading…
Apr-10-24 09:30PM
Apr-02-24 08:30AM
Mar-29-24 11:30AM
Mar-25-24 11:46PM
Mar-15-24 09:32AM
Mar-13-24 06:00PM
Mar-08-24 07:30PM
Mar-05-24 08:00AM
Feb-29-24 11:34AM
Feb-28-24 05:35PM
04:05PM Loading…
Feb-21-24 04:05PM
Feb-09-24 09:15PM
Feb-05-24 07:00AM
Jan-23-24 11:44AM
Jan-19-24 09:30PM
Jan-16-24 08:30AM
Jan-15-24 04:03AM
Jan-10-24 07:00PM
Jan-08-24 08:30AM
Jan-03-24 08:45AM
Dec-18-23 01:05PM
Dec-08-23 07:30PM
Nov-30-23 09:45AM
Nov-20-23 04:05PM
Nov-13-23 02:00PM
Nov-10-23 05:30PM
Nov-06-23 09:10AM
Nov-03-23 08:30AM
Nov-02-23 07:13PM
Oct-30-23 10:00AM
Oct-27-23 08:45AM
Oct-17-23 04:30PM
Oct-11-23 04:52PM
Oct-10-23 08:00PM
Oct-07-23 05:00PM
Oct-02-23 08:30AM
Sep-26-23 08:30AM
Sep-21-23 08:30AM
Sep-15-23 03:05PM
Sep-14-23 01:15PM
Sep-13-23 01:01PM
Sep-11-23 10:07AM
Sep-08-23 11:30PM
Sep-06-23 11:19AM
Sep-05-23 08:30AM
Aug-10-23 07:00PM
Aug-03-23 05:25PM
Jul-27-23 04:05PM
Jul-25-23 05:12PM
Jul-20-23 08:18AM
Jul-18-23 10:48AM
Jul-17-23 02:18PM
Jul-10-23 08:00PM
Jun-29-23 09:27AM
Jun-23-23 12:00PM
Jun-14-23 08:30AM
Jun-09-23 09:30PM
Jun-07-23 08:30AM
Jun-02-23 08:49AM
May-19-23 07:00AM
May-18-23 08:30AM
May-17-23 08:30AM
May-11-23 08:30AM
May-10-23 09:00PM
May-09-23 02:59PM
May-06-23 08:05AM
May-04-23 06:05PM
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BJERKHOLT ERICCHIEF FINANCIAL OFFICERMar 27 '24Buy24.802,00049,60014,000Mar 27 08:47 PM
Radovich PeterPRESIDENT AND COOMar 25 '24Sale25.804,303111,01729,013Mar 25 05:41 PM
BJERKHOLT ERICCHIEF FINANCIAL OFFICERMar 18 '24Buy25.802,00051,60012,000Mar 18 05:34 PM
Peetz ChristopherCHIEF EXECUTIVE OFFICERFeb 02 '24Sale26.196,013157,491104,112Feb 05 09:04 PM
Radovich PeterPRESIDENT AND COOFeb 02 '24Sale26.191,79046,88334,695Feb 05 09:05 PM
Vig PamelaCHIEF SCIENTIFIC OFFICERFeb 02 '24Sale26.191,21431,79728,691Feb 05 09:12 PM
Longpre LaraCHIEF DEVELOPMENT OFFICERFeb 02 '24Sale26.1984722,184104,407Feb 05 09:10 PM
Howe JolandaSVP, GLOBAL CONTROLLERFeb 02 '24Sale26.1973519,2511,759Feb 02 09:28 PM
Peetz ChristopherPRESIDENT AND CEOJan 08 '24Sale28.035,209146,033110,125Jan 09 08:12 PM
Radovich PeterCHIEF OPERATING OFFICERJan 08 '24Sale28.031,40839,47336,485Jan 09 08:28 PM
Vig PamelaHEAD OF RESEARCH & DEVELOPMENTJan 08 '24Sale28.031,40839,47229,905Jan 09 08:21 PM
Longpre LaraCHIEF DEVELOPMENT OFFICERJan 08 '24Sale28.041,01928,568105,254Jan 09 08:25 PM
Howe JolandaSVP, GLOBAL CONTROLLERJan 08 '24Sale28.0452814,803722Jan 09 08:09 PM
Howe JolandaSVP, Global ControllerDec 05 '23Option Exercise2.942,5007,3502,500Dec 06 05:16 PM
Howe JolandaSVP, Global ControllerDec 05 '23Sale32.402,50081,0000Dec 06 05:16 PM
GREY MICHAEL GDirectorSep 14 '23Option Exercise2.9414,21641,73814,216Sep 14 07:33 PM
GREY MICHAEL GDirectorSep 14 '23Sale32.0014,216454,9120Sep 14 07:33 PM
GREY MICHAEL GDirectorSep 13 '23Option Exercise2.943921,151392Sep 14 07:33 PM
Heron Patrick JDirectorSep 13 '23Buy31.022,62581,425159,053Sep 15 04:56 PM
GREY MICHAEL GDirectorSep 13 '23Sale32.0039212,5440Sep 14 07:33 PM
Heron Patrick JDirectorSep 12 '23Buy30.603,750114,764156,428Sep 13 04:39 PM
BJERKHOLT ERICChief Financial OfficerSep 11 '23Buy29.6510,000296,49210,000Sep 12 06:23 PM
Heron Patrick JDirectorSep 11 '23Buy30.304,687142,027152,678Sep 13 04:39 PM
Heron Patrick JDirectorAug 31 '23Buy26.25147,9913,884,764147,991Sep 05 12:51 PM
Howe JolandaSVP, Global ControllerAug 25 '23Sale26.233,45990,7430Aug 28 04:30 PM
Peetz ChristopherPresident and CEOJul 03 '23Sale25.655,498141,005115,334Jul 05 07:30 PM
Radovich PeterChief Operating OfficerJul 03 '23Sale25.651,42536,54637,675Jul 05 07:47 PM
Vig PamelaHead of Research & DevelopmentJul 03 '23Sale25.651,42536,54630,786Jul 05 07:35 PM
Longpre LaraChief Development OfficerJul 03 '23Sale25.651,00425,749105,839Jul 05 07:37 PM
Howe JolandaSVP, Global ControllerJul 03 '23Sale25.6591523,4673,459Jul 05 07:33 PM
GREY MICHAEL GDirectorJun 08 '23Option Exercise2.9414,60842,88914,608Jun 09 04:20 PM
GREY MICHAEL GDirectorJun 08 '23Sale29.0014,608423,6320Jun 09 04:20 PM